Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

SRA

Serono (SRA)

Serono S A
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:SRA
DateHeureSourceTitreSymboleSociété
17/01/201109h32PR Newswire (US)Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's DiseaseNYSE:SRASerono S A
12/01/201109h01PR Newswire (US)Brighter Futures in MS - Inspiring Short Film Premieres in BrusselsNYSE:SRASerono S A
13/12/201012h00PR Newswire (US)Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative DiseasesNYSE:SRASerono S A
26/11/201008h00PR Newswire (US)Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of MuNYSE:SRASerono S A
17/11/201008h46PR Newswire (US)Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MSNYSE:SRASerono S A
15/11/201008h30PR Newswire (US)Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in EuropeNYSE:SRASerono S A
04/11/201007h00PR Newswire (US)Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson'sNYSE:SRASerono S A
28/10/201016h33PR Newswire (US)Merck Serono Sells Théramex to Teva for EUR 265 MillionNYSE:SRASerono S A
25/10/201011h19PR Newswire (US)Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs ofNYSE:SRASerono S A
15/10/201015h30PR Newswire (US)Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple SclerosisNYSE:SRASerono S A
13/10/201009h00PR Newswire (US)Merck Serono: New Presentation of Cyanokit(R) Approved in EuropeNYSE:SRASerono S A
11/10/201008h00PR Newswire (US)Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MSNYSE:SRASerono S A
11/10/201007h30PR Newswire (US)Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies (R)NYSE:SRASerono S A
03/08/201012h38PR Newswire (US)Merck Serono Calls for Entries to Real MS - Your Story, a Global Competition to Raise Awareness of Multiple SclerosisNYSE:SRASerono S A
28/07/201009h05PR Newswire (US)Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MSNYSE:SRASerono S A
12/07/201008h00PR Newswire (US)Merck Serono's Cladribine Tablets for MS Approved in RussiaNYSE:SRASerono S A
29/06/201008h00PR Newswire (US)Merck Serono to Award Grant to Innovative Research Projects in FertilityNYSE:SRASerono S A
10/06/201007h30PR Newswire (US)Merck Serono: Data on Safinamide to Be Presented at the 14th MDS MeetingNYSE:SRASerono S A
08/06/201008h00PR Newswire (US)Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS TherapyNYSE:SRASerono S A
26/05/201010h00PR Newswire (US)Your Story, Your Voice, Your Achievements, Your Ideas ... This Is About Life, Real Life, Real MSNYSE:SRASerono S A
25/05/201009h07PR Newswire (US)International Thyroid Awareness Week 2010 to Focus on Thyroid Disorders and PregnancyNYSE:SRASerono S A
31/03/201009h00PR Newswire (US)Data from Merck Serono's Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of NeurNYSE:SRASerono S A
10/10/200807h00PR Newswire (US)Merck Serono Named as a Top Employer by Science MagazineNYSE:SRA
06/07/200711h01PR Newswire (US)Squeeze Out of Merck Serono Shares Successfully CompletedNYSE:SRA
27/04/200700h56PR Newswire (US)HealthShares(TM) Announces Changes to the HealthShares(TM) Dermatology & Wound Care, Emerging Cancer, and Composite IndexesNYSE:SRASerono S A
05/04/200717h00PR Newswire (US)Merck Serono S.A. to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American DNYSE:SRASerono S A
21/03/200711h08PR Newswire (US)Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.NYSE:SRA
21/03/200708h15PR Newswire (US)Merck Serono Confirms Previously Announced 2006 FiguresNYSE:SRA
01/03/200707h15PR Newswire (US)Merck KGaA Announces Serono Preliminary Figures for 2006NYSE:SRA
28/02/200710h54PR Newswire (US)Merck Serono S.A. Preliminary Q4/FY 06 Results - March 1NYSE:SRASerono S A
 Showing the most relevant articles for your search:NYSE:SRA